A tabletability change classification system in supporting the tablet formulation design via the roll compaction and dry granulation process

IF 5.2 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Junhui Su , Kunfeng Zhang , Feiyu Qi , Junjie Cao , Yuhua Miao , Zhiqiang Zhang , Yanjiang Qiao , Bing Xu
{"title":"A tabletability change classification system in supporting the tablet formulation design via the roll compaction and dry granulation process","authors":"Junhui Su ,&nbsp;Kunfeng Zhang ,&nbsp;Feiyu Qi ,&nbsp;Junjie Cao ,&nbsp;Yuhua Miao ,&nbsp;Zhiqiang Zhang ,&nbsp;Yanjiang Qiao ,&nbsp;Bing Xu","doi":"10.1016/j.ijpx.2023.100204","DOIUrl":null,"url":null,"abstract":"<div><p>In this paper, the material library approach was used to uncover the pattern of tabletability change and related risk for tablet formulation design under the roll compaction and dry granulation (RCDG) process. 31 materials were fully characterized using 18 physical parameters and 9 compression behavior classification system (CBCS) parameters. Then, each material was dry granulated and sieved into small granules (125–250 μm) and large granules (630–850 μm), respectively. The compression behavior of granules was characterized by the CBCS descriptors, and were compared with that of ungranulated powders. The relative change of tabletability (<em>CoT</em><sub>r</sub>) index was used to establish the tabletability change classification system (TCCS), and all materials were classified into three types, i.e. loss of tabletability (LoT, Type I), unchanged tabletability (Type II) and increase of tabletability (Type III). Results showed that approximately 65% of materials presented LoT, and as the granules size increased, 84% of the materials exhibited LoT. A risk decision tree was innovatively proposed by joint application of the CBCS tabletability categories and the TCCS tabletability change types. It was found that the LoT posed little risk to the tensile strength of the final tablet, when Category 1 or 2A materials, or Category 2B materials with Type II or Type III change of tabletability were used. Formulation risk happened to Category 2C or 3 materials, or Category 2B materials with Type I change of tabletability, particularly when high proportions of these materials were involved in tablet formulation. In addition, the risk assessment results were verified in the material property design space developed from a latent variable model in prediction of tablet tensile strength. Overall, results suggested that a combinational use of CBCS and TCCS could aid the decision making in selecting materials for tablet formulation design via RCDG.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100204"},"PeriodicalIF":5.2000,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407897/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics: X","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590156723000488","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

In this paper, the material library approach was used to uncover the pattern of tabletability change and related risk for tablet formulation design under the roll compaction and dry granulation (RCDG) process. 31 materials were fully characterized using 18 physical parameters and 9 compression behavior classification system (CBCS) parameters. Then, each material was dry granulated and sieved into small granules (125–250 μm) and large granules (630–850 μm), respectively. The compression behavior of granules was characterized by the CBCS descriptors, and were compared with that of ungranulated powders. The relative change of tabletability (CoTr) index was used to establish the tabletability change classification system (TCCS), and all materials were classified into three types, i.e. loss of tabletability (LoT, Type I), unchanged tabletability (Type II) and increase of tabletability (Type III). Results showed that approximately 65% of materials presented LoT, and as the granules size increased, 84% of the materials exhibited LoT. A risk decision tree was innovatively proposed by joint application of the CBCS tabletability categories and the TCCS tabletability change types. It was found that the LoT posed little risk to the tensile strength of the final tablet, when Category 1 or 2A materials, or Category 2B materials with Type II or Type III change of tabletability were used. Formulation risk happened to Category 2C or 3 materials, or Category 2B materials with Type I change of tabletability, particularly when high proportions of these materials were involved in tablet formulation. In addition, the risk assessment results were verified in the material property design space developed from a latent variable model in prediction of tablet tensile strength. Overall, results suggested that a combinational use of CBCS and TCCS could aid the decision making in selecting materials for tablet formulation design via RCDG.

Abstract Image

一种通过碾压和干燥造粒工艺来支持片剂配方设计的片性变化分级系统
在本文中,使用材料库方法揭示了在辊压和干燥制粒(RCDG)工艺下片剂配方设计的可压片性变化模式和相关风险。利用18个物理参数和9个压缩行为分类系统(CBCS)参数对31种材料进行了全面表征。然后,将每种材料干燥制粒,并分别筛成小颗粒(125–250μm)和大颗粒(630–850μm)。用CBCS描述符表征了颗粒的压缩行为,并与未颗粒粉末的压缩行为进行了比较。利用可压片性相对变化(CoTr)指数建立可压片性变化分类系统(TCCS),将所有材料分为三类,即可压片性损失(LoT,i型)、可压片性不变(II型)和可压片性增加(III型)。结果显示,大约65%的材料呈现LoT,并且随着颗粒尺寸的增加,84%的材料呈现出LoT。通过CBCS可压片性类别和TCCS可压片变化类型的联合应用,创新性地提出了风险决策树。发现当使用1类或2A类材料或具有II类或III类可压片性变化的2B类材料时,LoT对最终片剂的拉伸强度几乎没有风险。配方风险发生在2C类或3类材料,或具有I类可压片性变化的2B类材料上,特别是当这些材料的高比例涉及片剂配方时。此外,在预测片剂拉伸强度的潜变量模型开发的材料性能设计空间中验证了风险评估结果。总之,结果表明,CBCS和TCCS的组合使用可以帮助通过RCDG选择片剂配方设计的材料。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Pharmaceutics: X
International Journal of Pharmaceutics: X Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
6.60
自引率
0.00%
发文量
32
审稿时长
24 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信